Jagson Pal Pharmaceuticals Ltd JAGSNPHARM-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 02/26/21 IST
91.65quote price arrow down-4.70 (-4.88%)
Volume
336,290
52 week range
16.25 - 102.00

...

Loading . . .

KEY STATS

  • Open95.00
  • Day High96.95
  • Day Low90.20
  • Prev Close96.35
  • 52 Week High102.00
  • 52 Week High Date02/25/21
  • 52 Week Low16.25
  • 52 Week Low Date03/23/20
  • Market Cap32.53M
  • Shares Out26.2M
  • 10 Day Average Volume426,451.92
  • Dividend0.50
  • Dividend Yield0.55%
  • Beta
  • 1 Year % Change228.49

RATIOS/PROFITABILITY

  • EPS (TTM)5.15
  • P/E (TTM)17.78
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/22/2020
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest Jagson Pal Pharmaceuticals Ltd News

There is no recent news for this security.

Latest JAGSNPHARM-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company engaged in manufacturing of pharmaceuticals and intermediate drugs. The Company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. It manufactures capsules, tablets and ampoules. It operates research and development, manufacturing, marketing and distribution facilities. It develops and manufactures active pharmaceutical ingredients (APIs) and formulations. It offers...
Rajpal Kochhar
Chairman
Sanjiv Dudeja
Chief Financial Officer
Address
T 210J, Shahpurjat
New Delhi
110049
India